Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of ClōSYS Oral Rinse for Oral Malodor
NCT03160573Completed
- Sponsor
- Rowpar Pharmaceuticals
- Start
- Nov 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules, Device-based Delivery
01
Overview
Randomised, double-blind trial of closys in halitosis (4 arms), sponsored by Rowpar Pharmaceuticals. Primary endpoint: Reduction in Malodor as Measured by Organoleptic Score at 3 weeks. Started Nov 2016; status: completed.
02
Drugs
closys
03
Conditions
halitosis
Beyond the preview
Go deeper on NCT03160573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03160573.